Business Description
Raphael Pharmaceutical Inc
NAICS : 325411
SIC : 2833
ISIN : US27785B2088
Description
Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. Its product is RaphaWell, which includes CBG and Sesame Oil Supplement.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -554 | |||||
Debt-to-Equity | -0.02 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.5 | |||||
3-Year EPS without NRI Growth Rate | 32.8 | |||||
3-Year FCF Growth Rate | 40.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 77.15 | |||||
14-Day RSI | 76.91 | |||||
12-1 Month Momentum % | 86.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.9 | |||||
Shareholder Yield % | 0.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -2900.54 | |||||
ROIC % | -2556.37 | |||||
3-Year ROIIC % | 6094.12 | |||||
ROC (Joel Greenblatt) % | -53000 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -26.64 | |||||
EV-to-EBITDA | -26.64 | |||||
EV-to-FCF | -627.47 | |||||
Earnings Yield (Greenblatt) % | -3.75 | |||||
FCF Yield % | -0.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RAPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Raphael Pharmaceutical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.06 | ||
| Beta | 1.8802 | ||
| 3-Year Sharpe Ratio | 0.69 | ||
| 3-Year Sortino Ratio | 1.91 | ||
| Volatility % | 214.24 | ||
| 14-Day RSI | 76.91 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 1.4 | ||
| 12-1 Month Momentum % | 86.67 | ||
| 52-Week Range ($) | 0.22 - 1.4 | ||
| Shares Outstanding (Mil) | 20.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Raphael Pharmaceutical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Raphael Pharmaceutical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Raphael Pharmaceutical Inc Frequently Asked Questions
What is Raphael Pharmaceutical Inc(RAPH)'s stock price today?
The current price of RAPH is $1.40. The 52 week high of RAPH is $1.40 and 52 week low is $0.22.
When is next earnings date of Raphael Pharmaceutical Inc(RAPH)?
The next earnings date of Raphael Pharmaceutical Inc(RAPH) is .
Does Raphael Pharmaceutical Inc(RAPH) pay dividends? If so, how much?
Raphael Pharmaceutical Inc(RAPH) does not pay dividend.
Guru Commentaries on OTCPK:RAPH
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Raphael Pharmaceutical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers